![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C20H26N2 |
Molar mass | 294.442 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Tetrindole was a drug candidate that functions byreversibly inhibitingmonoamine oxidase A; it was first synthesized in Moscow in the early 1990s.[1] Tetrindole is similar in its chemical structure topirlindole (Pyrazidol), andmetralindole.[2]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |